文献速递心脏核医学

使用新型68Ga-mCXCL12 PET示踪剂对小鼠急性心肌梗死模型心脏CXCR4表达的分子影像

Molecular imaging of cardiac CXCR4 expression in a mouse model of acute myocardial infarction using a novel 68Ga-mCXCL12 PET tracer.
PubMed 文献 · J Nucl Cardiol · 2020-07-16

研究在小鼠心肌梗死后第1-6天静脉注射68Ga-mCXCL12,进行体外放射自显影和体内PET成像,评估心脏CXCR4表达。体外放射自显影显示梗死区CXCR4上调,梗死/远端比值在12小时后为1.4±0.3,至第2天显著增至4.5±0.6,随后平台期并于10天后降至1.3±1.0;体内PET显示梗死区摄取在第3天前后达峰(9.7±5.0 %ID/g),第6天降至2.8±1.0 %ID/g。结论认为该示踪剂用于无创分子成像检测心脏CXCR4表达在体外和体内均可行。

要点

  • 68Ga-mCXCL12 PET示踪剂可在小鼠心肌梗死后无创定量心脏CXCR4表达。
  • 体外放射自显影梗死/远端比值第2天达4.5±0.6,第10天降至1.3±1.0。
  • 体内PET梗死区摄取第3天前后峰值9.7±5.0 %ID/g,第6天2.8±1.0 %ID/g。

核心结论

  • 使用新型、基于小鼠且特异性的68Ga-mCXCL12示踪剂对心脏CXCR4表达进行无创分子成像在体外和体内均可行。

研究设计与样本

  • 研究在小鼠心肌梗死模型中进行,于梗死后第1-6天静脉注射68Ga-mCXCL12,并开展体外放射自显影与体内PET成像,同时行18F-FDG-PET用于解剖定位。

主要发现

  • 体外放射自显影显示梗死区CXCR4上调,梗死/远端比值12小时后为1.4±0.3,至第2天显著增至4.5±0.6,第4天进入平台期,10天后降至1.3±1.0。
  • 体内PET成像显示梗死区CXCR4上调,摄取在第3天前后达峰,为9.7±5.0 %ID/g,第6天降至2.8±1.0 %ID/g。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The chemokine receptor CXCR4 and its ligand CXCL12 have been shown to be a possible imaging and therapeutic target after myocardial infarction (MI). The murine-based and mouse-specific 68Ga-mCXCL12 PET tracer could be suitable for serial in vivo quantification of cardiac CXCR4 expression in a murine model of MI. METHODS AND RESULTS: At days 1-6 after MI, mice were intravenously injected with 68Ga-mCXCL12. Autoradiography was performed and the infarct-to-remote ratio (I/R) was determined. In vivo PET imaging with 68Ga-mCXCL12 was conducted on days 1-6 after MI and the percentage of the injected dose (%ID/g) of the tracer uptake in the infarct area was calculated. 18F-FDG-PET was performed for anatomical landmarking. Ex vivo autoradiography identified CXCR4 upregulation in the infarct region with an increasing I/R after 12 hours (1.4 ± 0.3), showing a significant increase until day 2 (4.5 ± 0.6), followed by a plateau phase (day 4) and decrease after 10 days (1.3 ± 1.0). In vivo PET imaging identified similar CXCR4 upregulation in the infarct region which peaked around day 3 post MI (9.7 ± 5.0 %ID/g) and then subsequently decreased by day 6 (2.8 ± 1.0 %ID/g). CONCLUSION: Noninvasive molecular imaging of cardiac CXCR4 expression using a novel, murine-based, and specific 68Ga-mCXCL12 tracer is feasible both ex vivo and in vivo.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Zacherl MJ, Todica A, Wängler C, et al. Molecular imaging of cardiac CXCR4 expression in a mouse model of acute myocardial infarction using a novel 68Ga-mCXCL12 PET tracer. J Nucl Cardiol. 2020. PMID: 32676914. doi:10.1007/s12350-020-02262-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。